| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |